HMGB2 and esophageal squamous cell carcinoma: Additionally, cytotoxicity assays against ESCC cell lines demonstrated that HMGB2 overexpression significantly impaired NK cell-mediated tumor cell killing, with reduced tumor cell lysis observed at multiple effector-to-target ratios (Figure 5e).